←
Max Eckmann1,035 posts
Max Eckmann avatar

Max Eckmann

@eckmann_max

Endowed Professor. President Texas Pain Society. Vice Chair for Clinical Research. Anesthesiology & Pain Medicine, @UTHealthSA

◷ Joined October 2017▧ 122 Photos and videos
Laxmaiah Manchikanti avatar
⟳ Max Eckmann retweeted
Laxmaiah Manchikanti@DrManchikanti·6 Oct 2023

CMS has published the 2024 Physician Fee Schedule, and the news is not good. A sequestration order will be issued if Congress does not act, reducing Medicare reimbursements by 4%. Join us in contacting every member of Congress! Link to sample letters: asipp.org/impending-medicare…

Post attachment
Regional Anesthesia & Pain Medicine avatar
⟳ Max Eckmann retweeted
Regional Anesthesia & Pain Medicine@RAPMOnline·6 Oct 2023

🔥🩺 Revolutionize Pain Relief! Discover the study comparing Cooled Radiofrequency Ablation to Standard Medical Management for Sacroiliac Joint Pain 🌡️🔬 "Elevating Pain Management: A Comparative Study" unveils groundbreaking insights. 👉 bit.ly/3qHrelA

UT Health San Antonio avatar
⟳ Max Eckmann retweeted
UT Health San Antonio@UTHealthSA·6 Oct 2023

Thank you to @SanAntonioWoman for highlighting the impressive work and accomplishments by Sudha Seshadri, MD — a UT Health San Antonio neurologist and founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases. Read more: bit.ly/3LQFL5F

Post attachment
Regional Anesthesia & Pain Medicine avatar
⟳ Max Eckmann retweeted
Regional Anesthesia & Pain Medicine@RAPMOnline·4 Oct 2023

🌟🩺 Explore the journal article "Easing Trigeminal Neuralgia: Pulsed Radiofrequency Treatment" 🌡️🔬 Discover the insights from the PROGRESS study, shedding light on Gasserian ganglion treatment. 👉 Read the full article here: bit.ly/3KXUon7

ASA® avatar
⟳ Max Eckmann retweeted
ASA®@ASALifeline·29 Mar 2023

ASA applauds the @US_FDA’s approval of over-the-counter sale of #naloxone, a life-saving medication used to reverse #opioid overdoses, and urges the public to learn how to recognize and respond to an overdose. Read more: ow.ly/1iwf50Nv0eT